TCL Archive Also NSABP’s STAR Trial Finds Raloxifene Equivalent To Tamoxifen For Breast Cancer Risk Reduction. April 21, 2006
TCL Archive In Brief: Comprehensive Designation To MN Center; Bernardin Center Wins NCI Planning Grant October 16, 1998